GILEAD SCIENCES, INC. (GILD)

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Address

333 LAKESIDE DR
FOSTER CITY, CA 94404

Founded

1987

Number of Employees

18,000

Website

http://www.gilead.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)		 $3,561 $7,243 $9,260 $934 $2,067 $1,747 $1,714 $631 $755 $1,094 $650 $2,696
Average Price $83.65 $105.28 $90.35 $71.02 $75.53 $66.43 $70.62 $66.32 $62.71 $79.82 $74.26 $84.99
# Shares Purchased 42,576 68,792 102,491 13,145 27,366 26,297 24,267 9,515 12,034 13,712 8,747 31,722
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date -2.0% -22.1% -9.2% 15.5% 8.6% 23.4% 16.1% 23.6% 30.8% 2.7% 10.4% -3.5%
S&P 500 Return to Date 181.9% 173.0% 168.6% 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% 7.4% 94.0%
Excess Total Return -183.8% -195.1% -177.8% -114.3% -96.3% -69.7% -58.7% -8.0% -6.5% -28.6% 3.0% -97.5%
Quartile Rank
Percentile Rank 30% 26% 28% 44% 40% 48% 38% 65% 70% 41% 62% 40%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
AbbVie Inc.
Merck & Co., Inc.
MERCK & CO., INC.

SUTRO BIOPHARMA, INC.
AMGEN INC